Levin Capital Strategies L.P. Has $1.23 Million Holdings in The Procter & Gamble Company (NYSE:PG)

Levin Capital Strategies L.P. lowered its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 3.1% during the fourth quarter, HoldingsChannel.com reports. The fund owned 8,411 shares of the company’s stock after selling 272 shares during the period. Levin Capital Strategies L.P.’s holdings in Procter & Gamble were worth $1,233,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. Wellington Management Group LLP lifted its holdings in shares of Procter & Gamble by 9.4% during the third quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock valued at $5,193,916,000 after acquiring an additional 3,047,557 shares during the period. Northern Trust Corp raised its stake in shares of Procter & Gamble by 2.3% in the third quarter. Northern Trust Corp now owns 29,313,150 shares of the company’s stock valued at $4,275,616,000 after acquiring an additional 670,862 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Procter & Gamble by 0.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company’s stock worth $2,298,184,000 after acquiring an additional 131,339 shares during the last quarter. Royal Bank of Canada grew its holdings in shares of Procter & Gamble by 3.2% during the third quarter. Royal Bank of Canada now owns 11,170,305 shares of the company’s stock worth $1,629,299,000 after purchasing an additional 346,925 shares during the last quarter. Finally, Fisher Asset Management LLC increased its stake in shares of Procter & Gamble by 5.6% in the fourth quarter. Fisher Asset Management LLC now owns 10,556,988 shares of the company’s stock valued at $1,547,021,000 after buying an additional 559,358 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Up 0.5 %

Shares of NYSE:PG traded up $0.76 during mid-day trading on Thursday, reaching $164.16. 3,257,526 shares of the stock were exchanged, compared to its average volume of 6,904,771. The company has a market cap of $387.44 billion, a P/E ratio of 26.75, a P/E/G ratio of 3.31 and a beta of 0.43. The stock’s 50 day simple moving average is $159.88 and its 200-day simple moving average is $153.97. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $164.49.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The business had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. During the same quarter in the prior year, the company posted $1.37 earnings per share. The firm’s revenue was up .6% on a year-over-year basis. As a group, equities research analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.45%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date of this dividend is Thursday, April 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.85%.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares of the company’s stock, valued at approximately $768,256.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Susan Street Whaley sold 3,865 shares of the stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $160.60, for a total transaction of $620,719.00. Following the completion of the transaction, the insider now directly owns 11,886 shares in the company, valued at $1,908,891.60. The disclosure for this sale can be found here. Insiders have sold a total of 86,865 shares of company stock worth $14,059,180 in the last 90 days. Corporate insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a report on Friday, March 1st. They set a “neutral” rating and a $168.00 price objective on the stock. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. Royal Bank of Canada lifted their target price on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 24th. Stifel Nicolaus upped their price target on Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. Finally, Truist Financial upgraded Procter & Gamble from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $169.76.

Get Our Latest Stock Analysis on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.